Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
University of North Carolina, Chapel Hill, North Carolina, USA.
J Am Coll Cardiol. 2022 Mar 1;79(8):819-836. doi: 10.1016/j.jacc.2021.12.016.
There is a need to identify high-risk features that predict early-onset atherosclerotic cardiovascular disease (ASCVD). The authors provide insights to help clinicians identify and address high-risk conditions in the 20- to 39-year age range (young adults). These include tobacco use, elevated blood pressure/hypertension, family history of premature ASCVD, primary severe hypercholesterolemia such as familial hypercholesterolemia, diabetes with diabetes-specific risk-enhancing factors, or the presence of multiple other risk-enhancing factors, including in females, a history of pre-eclampsia or menopause under age 40. The authors update current thinking on lipid risk factors such as triglycerides, non-high-density lipoprotein cholesterol, apolipoprotein B, or lipoprotein (a) that are useful in understanding an individual's long-term ASCVD risk. The authors review emerging strategies, such as coronary artery calcium and polygenic risk scores in this age group, that have potential clinical utility, but whose best use remains uncertain. Finally, the authors discuss both the obstacles and opportunities for addressing prevention in early adulthood.
需要确定预测早发性动脉粥样硬化性心血管疾病(ASCVD)的高危特征。作者提供了一些见解,以帮助临床医生识别和处理 20 至 39 岁年龄段(年轻人)的高危情况。这些情况包括吸烟、血压升高/高血压、早发性 ASCVD 的家族史、家族性高胆固醇血症等原发性严重高胆固醇血症、有糖尿病特异性风险增强因素的糖尿病,或存在多种其他风险增强因素,包括女性有先兆子痫或 40 岁以下绝经史。作者更新了当前对血脂风险因素的认识,如甘油三酯、非高密度脂蛋白胆固醇、载脂蛋白 B 或脂蛋白(a),这些因素有助于了解个体的长期 ASCVD 风险。作者还回顾了在该年龄段具有潜在临床应用价值的新兴策略,如冠状动脉钙和多基因风险评分,但最佳应用仍不确定。最后,作者讨论了在成年早期进行预防的障碍和机会。
J Am Coll Cardiol. 2022-3-1
Trends Cardiovasc Med. 2019-2-19
J Formos Med Assoc. 2017-4
Biomedicines. 2025-7-24
Mayo Clin Proc. 2025-7-23
Am J Prev Cardiol. 2025-5-24
Front Endocrinol (Lausanne). 2025-5-29
Curr Cardiol Rep. 2025-6-12